PWM
LLY icon

Proathlete Wealth Management’s Eli Lilly LLY Stock Holding History

Proathlete Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$214K Buy
232
+63
+37% +$63.9K 0.06% 61
2025
Q4 		$182K Hold
169
– – 0.05% 69
2025
Q3 		$129K Sell
169
-3
-2% -$2.23K 0.04% 82
2025
Q2 		$134K Buy
172
+45
+35% +$35K 0.04% 74
2025
Q1 		$105K Buy
+127
New +$106K 0.04% 87

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Proathlete Wealth Management's LLY Position: Q1 2026 in Review

Proathlete Wealth Management increased its Eli Lilly (LLY) stake by 37% in Q1 2026, buying an estimated $63.9K and bringing the position to 232 shares worth $214K. The position accounts for 0.06% of the portfolio, ranked #61.

Proathlete Wealth Management first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Proathlete Wealth Management held 232 shares of Eli Lilly worth $214K as of Q1 2026.
  • Proathlete Wealth Management bought 63 Eli Lilly shares in Q1 2026, an estimated $63.9K.
  • Eli Lilly made up 0.06% of Proathlete Wealth Management's portfolio in Q1 2026, its #61 holding.
  • Proathlete Wealth Management first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Proathlete Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.